JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sundaram, S. K.
Right arrow Articles by Bacharach, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sundaram, S. K.
Right arrow Articles by Bacharach, S. L.
Journal of Nuclear Medicine Vol. 45 No. 8 1328-1333
© 2004 by Society of Nuclear Medicine


Clinical Investigations

Simplified Kinetic Analysis of Tumor 18F-FDG Uptake: A Dynamic Approach

Senthil K. Sundaram, MD1, Nanette M.T. Freedman, PhD2, Jorge A. Carrasquillo, MD1, Joann M. Carson1, Millie Whatley, BS1, Steven K. Libutti, MD1, David Sellers, RN1 and Stephen L. Bacharach, PhD1

1 National Institutes of Health, Bethesda, Maryland
2 Hadassah University Hospital, Jerusalem, Israel

Standardized uptake value (SUV) is often used to quantify 18F-FDG tumor use. Although useful, SUV suffers from known quantitative inaccuracies. Simplified kinetic analysis (SKA) methods have been proposed to overcome the shortcomings of SUV. Most SKA methods rely on a single time point (SKA-S), not on tumor uptake rate. We describe a hybrid between Patlak analysis and existing SKA-S methods, using multiple time points (SKA-M) but reduced imaging time and without measurement of an input function. We compared SKA-M with a published SKA-S method and with Patlak analysis. Methods: Twenty-seven dynamic 18F-FDG scans were performed on 11 cancer patients. A population-based 18F-FDG input function was generated from an independent patient population. SKA-M was calculated using this population input function and either a short, late, dynamic acquisition over the tumor (starting 25–35 min after injection and ending ~55 min after injection) or dynamic imaging 10 or 25 min to ~55 min after injection but using only every second or third time point, to permit a 2- or 3-field-of-view study. SKA-S was also calculated. Both SKA-M and SKA-S were compared with the gold standard, Patlak analysis. Results: Both SKA-M (1 field of view) and SKA-S correlated well with Patlak slope (r > 0.99, P < 0.001, and r = 0.96, P < 0.001, respectively), as did multilevel SKA-M (r > 0.99 and P < 0.001 for both). Mean values of SKA-M (25-min start time) and SKA-S were statistically different from Patlak analysis (P < 0.001 and P < 0.04, respectively). One-level SKA-M differed from the Patlak influx constant by only –1.0% ± 1.4%, whereas SKA-S differed by 15.1% ± 3.9%. With 1-level SKA-M, only 2 of 27 studies differed from Ki by more than 20%, whereas with SKA-S, 10 of 27 studies differed by more than 20% from Ki. Conclusion: Both SKA-M and SKA-S compared well with Patlak analysis. SKA-M (1 or multiple levels) had lower variability and bias than did SKA-S, compared with Patlak analysis. SKA-M may be preferred over SUV or SKA-S when a large unmetabolized 18F-FDG fraction is expected and 1–3 fields of view are sufficient.

Key Words: 18F-FDG • Patlak • standardized uptake value


Related articles in JNM:

THIS MONTH IN JNM

JNM 2004 45: 8A-9A. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
T. Schroeder, M. F. Vidal Melo, G. Musch, R. S. Harris, J. G. Venegas, and T. Winkler
Image-Derived Input Function for Assessment of 18F-FDG Uptake by the Inflamed Lung
J. Nucl. Med., November 1, 2007; 48(11): 1889 - 1896.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Soret, S. L. Bacharach, and I. Buvat
Partial-Volume Effect in PET Tumor Imaging
J. Nucl. Med., June 1, 2007; 48(6): 932 - 945.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. K. Shankar, J. M. Hoffman, S. Bacharach, M. M. Graham, J. Karp, A. A. Lammertsma, S. Larson, D. A. Mankoff, B. A. Siegel, A. Van den Abbeele, et al.
Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials
J. Nucl. Med., June 1, 2006; 47(6): 1059 - 1066.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.